Genomed Spólka Akcyjna (WSE:GEN)
28.60
+1.00 (3.62%)
At close: Jul 23, 2026
Genomed Spólka Akcyjna Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 5.53 | 6.1 | 5.24 | 5.26 | 3.49 | 4.92 |
Cash & Short-Term Investments | 5.53 | 6.1 | 5.24 | 5.26 | 3.49 | 4.92 |
Cash Growth | 15.36% | 16.37% | -0.37% | 50.81% | -29.08% | 9.72% |
Accounts Receivable | - | 2.83 | 1.53 | 1.72 | 1.3 | 1.12 |
Other Receivables | - | 0.17 | 0.07 | 0.06 | 0.16 | 0.15 |
Total Trade Receivables | 3.53 | 3 | 1.6 | 1.79 | 1.46 | 1.27 |
Inventory | 1.74 | 2.04 | 2.14 | 2.02 | 2.07 | 1.24 |
Other Current Assets | 0.27 | 0.48 | 0.21 | 0.36 | 0.24 | 0.16 |
Total Current Assets | 11.08 | 11.61 | 9.19 | 9.42 | 7.26 | 7.59 |
Net Property, Plant & Equipment | 2.65 | 2.84 | 2.13 | 1.2 | 1.7 | 2.17 |
Other Intangible Assets | 0.05 | 0.06 | 0.08 | 0.09 | 0.01 | 0.01 |
Long-Term Investments | - | - | - | 0.01 | 0.04 | - |
Other Long-Term Assets | 2.01 | 2.01 | 0.99 | 0.17 | 0.15 | 0.56 |
Total Assets | 15.79 | 16.53 | 12.4 | 12.12 | 10.38 | 10.33 |
Accounts Payable | - | 0.8 | 0.48 | 0.95 | 0.4 | 0.81 |
Accrued Expenses | - | 1.06 | 0.81 | 0.76 | 0.62 | 0.5 |
Other Current Liabilities | - | 0.01 | 0.02 | 0 | 0.02 | 0.01 |
Total Current Liabilities | 1.35 | 2.04 | 1.31 | 1.71 | 1.04 | 1.32 |
Long-Term Debt | - | - | - | 0.01 | 0.02 | 0.04 |
Other Long-Term Liabilities | 0.37 | 0.37 | 0.37 | 0.34 | 0.18 | 0.17 |
Total Long-Term Liabilities | 0.37 | 0.37 | 0.37 | 0.35 | 0.2 | 0.21 |
Total Liabilities | 1.72 | 2.41 | 1.68 | 2.06 | 1.24 | 1.53 |
Common Stock | -8.57 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 |
Treasury Stock | - | - | - | -1.22 | -1.22 | - |
Additional Paid-in Capital | 1.88 | 10.59 | 9.48 | 9 | 8.66 | 7.43 |
Retained Earnings | 3.35 | 3.4 | 1.11 | 0.93 | 0.34 | 1.24 |
Shareholders' Equity | 14.07 | 14.12 | 10.72 | 10.06 | 9.13 | 8.8 |
Total Liabilities & Equity | 15.79 | 16.53 | 12.4 | 12.12 | 10.38 | 10.33 |
Total Debt | - | 0 | 0 | 0.01 | 0.02 | 0.04 |
Net Cash (Debt) | 5.53 | 6.1 | 5.24 | 5.26 | 3.47 | 4.88 |
Net Cash Growth | 15.36% | 16.37% | -0.25% | 51.58% | -29.01% | 34.15% |
Net Cash Per Share | 4.18 | 4.62 | 3.97 | 3.98 | 2.62 | 3.70 |
Book Value | 14.07 | 14.12 | 10.72 | 10.06 | 9.13 | 8.8 |
Book Value Per Share | 10.65 | 10.68 | 8.11 | 7.61 | 6.91 | 6.66 |
Tangible Book Value | 14.02 | 14.06 | 10.64 | 9.97 | 9.13 | 8.78 |
Tangible Book Value Per Share | 10.61 | 10.64 | 8.05 | 7.55 | 6.91 | 6.65 |